Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Immunomodulatory cytokines and clonal dynamics in low-risk myelodysplastic syndromes patients treated with luspatercept.
Am J Hematol. 2023 Nov;98(11):E345-E348. doi: 10.1002/ajh.27072. Epub 2023 Sep 12.
Am J Hematol. 2023.
PMID: 37698348
No abstract available.
Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an "Old-fashioned" Drug be Effective?
Riva M, Bosi A, Rizzo L, Mazzon F, Ferrari S, Lussana F, Borin L, Castelli A, Cairoli R, Barcellini W, Molteni A, Fattizzo B.
Riva M, et al. Among authors: mazzon f.
Hemasphere. 2023 Mar 27;7(4):e867. doi: 10.1097/HS9.0000000000000867. eCollection 2023 Apr.
Hemasphere. 2023.
PMID: 36999006
Free PMC article.
No abstract available.
Item in Clipboard
Switching to an alternative recombinant erythropoietin agent in patients with myelodysplastic syndromes: a second honeymoon?
Fattizzo B, Rizzo L, Giannotta JA, Mazzon F, Cecchi N, Frangi C, Barcellini W, Riva M.
Fattizzo B, et al. Among authors: mazzon f.
Br J Haematol. 2021 Nov;195(4):e147-e150. doi: 10.1111/bjh.17722. Epub 2021 Jul 26.
Br J Haematol. 2021.
PMID: 34312838
Free article.
No abstract available.
Item in Clipboard
Cite
Cite